Pope Leo XIV's lung cancer diagnosis has renewed attention on non-smokers, who can face delayed diagnoses despite risks including radon, genetics, second-hand smoke and pollution.
Travere Therapeutics, Inc. (Nasdaq: TVTX) today presented new biomarker data from the Phase 3 PROTECT Study providing ...
Verywell Health on MSN
How kidney disease is diagnosed
Medically reviewed by Matthew Wosnitzer, MD Key Takeaways The main tests for kidney disease are an estimated glomerular filtration rate (eGFR) blood test and a urine albumin-to-creatinine ratio (UACR) ...
Johnson & Johnson : advances the next generation of solid tumor therapies with new data at ESMO 2026
In December 2025, Johnson & Johnson completed its acquisition of Halda Therapeutics, adding JNJ-6143 and the RIPTAC platform to its oncology portfolio.
The oral, once-daily EGFR inhibitor is now in specialty distribution for patients whose disease progressed after ...
AstraZeneca announced the US availability of ZEGFROVY® (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal ...
ZEGFROVY is now available in the US for post-platinum EGFR exon 20 insertion NSCLC after a 46% response rate in WU-KONG1B.
Launch expands AstraZeneca’s commitment to addressing substantial unmet need across the spectrum of EGFR-mutated lung cancer ...
In a cross-sectional study of 240 patients with chronic kidney disease, higher serum BDNF levels and a ...
Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...
Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through ...
Two oral presentations to highlight new 76-week data showing sustained proteinuria reduction and continued eGFR stabilization with a consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results